AUG8 Antibody

Shipped with Ice Packs
In Stock

Description

Augustine Blood Group System (AUG antigens)

The Augustine (AUG) blood group system involves four high- or low-frequency antigens (AUG1–AUG4) located on the ENT1 protein encoded by SLC29A1. These antigens are clinically significant in transfusion medicine and pregnancy:

  • AUG2 (At<sup>a</sup>) antibodies have caused hemolytic transfusion reactions .

  • AUG3 antibodies were linked to severe hemolytic disease of the fetus and newborn .

No AUG8 antigen or antibody is documented in this system. The numbering (AUG1–AUG4) reflects the order of discovery, not a sequence extending to "AUG8" .

Anti-AAV8 Neutralizing Antibodies

Anti-AAV8 neutralizing antibodies (NAbs) target adeno-associated virus serotype 8 (AAV8), a vector used in gene therapy. Key findings from a multicenter study of hemophilia patients include :

ParameterAAV8 NAbs Prevalence (%)AAV2 NAbs Prevalence (%)AAV5 NAbs Prevalence (%)
Baseline46.953.153.4
Year 147.250.052.8
Year 246.751.151.1

These antibodies persist over time and impact eligibility for AAV-based gene therapies .

Anti-Oxoguanine 8 Antibody (ab206461)

This monoclonal antibody targets 8-oxoguanine (8-oxo-G), a DNA lesion caused by oxidative stress. Key characteristics :

PropertyDetail
Host SpeciesMouse
ClonalityMonoclonal (Clone 2Q2311)
IsotypeIgM
ApplicationsELISA, IHC, ICC/IF
ReactivitiesModified amino acids (human samples)
Citations12 publications, 1 independent review

It is used to detect oxidative DNA damage in research contexts, such as in HeLa cells .

Critical Analysis of Potential Misinterpretations

  • Terminology Confusion: "AUG8" may result from conflating:

    • AUG antigens (Augustine system, limited to AUG1–AUG4) .

    • AAV8 (adeno-associated virus serotype 8) .

    • 8-oxoguanine (abbreviated 8-oxo-G or Oxoguanine 8) .

  • Database Coverage: The Antibody Registry catalogs over 2.5 million antibodies but lists no entries for "AUG8" .

Recommendations for Further Research

  1. Validate the intended target (e.g., AAV8, 8-oxoguanine, or a novel antigen).

  2. Consult antibody registries (e.g., Antibody Registry RRID:SCR_006397) for updates .

  3. Explore ENT1-related pathologies (e.g., pseudogout in AUG<sub>null</sub> individuals) if investigating Augustine system extensions.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
AUG8 antibody; QWRF8 antibody; REN2 antibody; At4g30710 antibody; T10C21.60AUGMIN subunit 8 antibody; QWRF motif-containing protein 8 antibody; ROP1 enhancer 2 antibody
Target Names
AUG8
Uniprot No.

Target Background

Function
AUG8 Antibody contributes to the assembly of the acentrosomal spindle and phragmoplast microtubule arrays as part of the augmin complex.
Database Links

KEGG: ath:AT4G30710

STRING: 3702.AT4G30710.1

UniGene: At.31806

Protein Families
QWRF family

Q&A

What is the AUG8 protein in Arabidopsis thaliana and what cellular processes is it involved in?

AUG8 (Q9SUH5) in Arabidopsis thaliana belongs to the augmin complex family of proteins that play crucial roles in microtubule organization during cell division. The protein is involved in nucleation of microtubules from existing microtubules, contributing to spindle formation and phragmoplast organization during mitosis and cytokinesis. Researchers typically use AUG8 antibodies to study microtubule dynamics, particularly during plant cell division processes where spindle organization and integrity are critical .

What are the recommended techniques for validating AUG8 antibody specificity in Arabidopsis samples?

Validation of AUG8 antibody specificity should follow a multi-step approach:

  • Western blot analysis using wild-type Arabidopsis and aug8 mutant lines

  • Immunoprecipitation followed by mass spectrometry

  • Immunolocalization studies comparing wild-type vs. aug8 knockout tissues

  • Peptide competition assays using the immunizing peptide

Always include appropriate positive and negative controls in each experiment. For negative controls, aug8 mutant lines or tissues where AUG8 expression is naturally absent should be used, while recombinant AUG8 protein can serve as a positive control .

Which experimental techniques are most suitable for studying AUG8 localization during different cell cycle phases?

For studying AUG8 localization across cell cycle phases, researchers should consider:

  • Immunofluorescence microscopy with cell cycle markers (DAPI for DNA, cyclin antibodies)

  • Live-cell imaging using GFP-tagged AUG8 in stable transformants

  • Super-resolution microscopy (SIM or STED) for detailed subcellular localization

  • Co-immunoprecipitation with cell cycle-specific proteins

For optimal results, synchronize Arabidopsis cell cultures using aphidicolin (G1/S block) or propyzamide (metaphase block) before fixation and immunostaining with the AUG8 antibody .

How should researchers design experiments to investigate AUG8 interactions with other augmin complex components?

When investigating AUG8 interactions with other augmin components:

  • Co-immunoprecipitation protocol: Use AUG8 antibody (CSB-PA154725XA01DOA) immobilized on protein A/G magnetic beads in extraction buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, protease inhibitors). Incubate with plant extracts for 2-3 hours at 4°C, wash 4-5 times, and analyze by Western blot with antibodies against other augmin subunits.

  • Proximity-dependent biotin identification (BioID): Generate transgenic Arabidopsis expressing AUG8-BioID fusions, treat with biotin, and identify interacting proteins by streptavidin pulldown followed by mass spectrometry.

  • Yeast two-hybrid screening: Use AUG8 as bait against an Arabidopsis cDNA library, focusing on identification of novel interactions.

  • Fluorescence resonance energy transfer (FRET): Express AUG8-CFP and potential interactors tagged with YFP to quantify in vivo protein-protein interactions in plant cells .

What are the optimal parameters for immunohistochemistry using AUG8 antibody in different plant tissues?

Optimal parameters for AUG8 immunohistochemistry vary by tissue type:

Tissue TypeFixationAntigen RetrievalAntibody DilutionIncubation ConditionsDetection System
Root tips4% PFA, 2h10mM citrate buffer, pH 6.0, 95°C, 10min1:20016h at 4°CFluorescent secondary 1:500
Leaf tissue4% PFA, 4h10mM citrate buffer, pH 6.0, 95°C, 15min1:10024h at 4°CFluorescent secondary 1:400
Meristematic tissue4% PFA, 2h10mM Tris-EDTA, pH 9.0, 95°C, 15min1:15018h at 4°CFluorescent secondary 1:500

For all tissues, include permeabilization with 0.2% Triton X-100 for 15 minutes after fixation and blocking with 3% BSA in PBS for 1 hour before antibody incubation. For negative controls, use pre-immune serum at the same concentration as the primary antibody .

How can researchers effectively use AUG8 antibody in chromatin immunoprecipitation (ChIP) experiments?

For ChIP experiments using AUG8 antibody:

  • Crosslinking: Fix plant tissue with 1% formaldehyde for 10 minutes under vacuum, quench with 0.125M glycine.

  • Chromatin preparation: Extract and shear chromatin to 200-500bp fragments using sonication (10-15 cycles of 30 seconds on/30 seconds off).

  • Immunoprecipitation: Pre-clear chromatin with protein A/G beads, then incubate with AUG8 antibody (2-5μg) overnight at 4°C. Add protein A/G beads for 2-3 hours.

  • Washes and elution: Perform stringent washing series (low salt, high salt, LiCl, and TE buffers). Elute with 1% SDS, 0.1M NaHCO₃ buffer at 65°C.

  • Reverse crosslinking and purification: Treat with proteinase K, reverse crosslink at 65°C overnight, purify DNA using phenol-chloroform extraction.

  • Analysis: Perform qPCR on regions of interest or submit for next-generation sequencing.

Optimize antibody concentration using a titration series (1-10μg per reaction) to determine minimal effective concentration for specific enrichment .

What are common causes of false positives/negatives when using AUG8 antibody, and how can researchers address them?

Common causes of false results with AUG8 antibody include:

False Positives:

  • Cross-reactivity with related proteins: Perform pre-absorption with recombinant related proteins

  • Non-specific binding to denatured proteins: Add 0.1% SDS to antibody dilution buffer

  • Insufficient blocking: Extend blocking time to 2 hours with 5% BSA or milk

False Negatives:

  • Epitope masking: Try multiple antigen retrieval methods (heat, enzymatic, high pH)

  • Antibody concentration too low: Optimize with titration series

  • Protein degradation: Add protease inhibitors freshly to all buffers

  • Overfixation: Reduce fixation time or try different fixatives

To validate results, always:

  • Include appropriate controls (positive, negative, secondary-only)

  • Confirm specificity with multiple detection methods

  • Validate with genetic approaches (aug8 mutants, RNAi lines)

How should researchers interpret contradictory data between AUG8 antibody results and transcriptome data?

When facing contradictions between AUG8 antibody results and transcriptome data:

  • Establish timeline: Protein expression often lags behind transcript levels, so consider temporal factors.

  • Methodologically validate: Confirm antibody specificity using western blot against recombinant AUG8 protein and aug8 knockout tissues.

  • Consider post-transcriptional regulation: Investigate potential miRNA targeting, RNA stability, or alternative splicing affecting AUG8 mRNA.

  • Examine post-translational modifications: Use phospho-specific or ubiquitin-specific antibodies to detect modified forms of AUG8.

  • Protein stability analysis: Perform cycloheximide chase experiments to determine AUG8 protein half-life.

  • Subcellular fractionation: Check if protein localization affects detection in different cellular compartments.

The systematic approach should include replicate experiments with both methods, potentially different antibody lots, and validation with alternative techniques such as mass spectrometry .

What statistical approaches are recommended for quantifying AUG8 immunofluorescence signal changes across experimental conditions?

For rigorous quantification of AUG8 immunofluorescence signals:

  • Image acquisition standardization:

    • Use identical microscope settings for all samples

    • Collect z-stacks of appropriate depth (0.3-0.5μm intervals)

    • Include fluorescence standards for calibration

  • Recommended quantification methods:

    • Integrated density measurements of defined ROIs

    • Background subtraction using adjacent negative regions

    • Signal-to-noise ratio calculations

  • Statistical analysis workflow:

    • Normality testing (Shapiro-Wilk test)

    • For normal distributions: ANOVA with post-hoc tests (Tukey's HSD)

    • For non-normal distributions: Kruskal-Wallis with Mann-Whitney U tests

    • Minimum sample size: 30-50 cells from ≥3 biological replicates

  • Data visualization:

    • Box plots showing median, quartiles, and outliers

    • Violin plots for distribution patterns

    • Include individual data points for transparency

For colocalization analysis with other proteins, use Pearson's or Mander's correlation coefficients with appropriate thresholding. Report Cohen's d for effect size alongside p-values .

How does AUG8 antibody specificity compare across different plant species beyond Arabidopsis?

AUG8 antibody (CSB-PA154725XA01DOA) cross-reactivity across plant species correlates with evolutionary conservation of the AUG8 protein sequence:

Plant SpeciesCross-ReactivityRequired Antibody DilutionNotes
Arabidopsis thalianaHigh (primary target)1:200-1:500Optimal specificity
Brassica speciesModerate-High1:100-1:200Recommended for close relatives
Rice (Oryza sativa)Low-Moderate1:50-1:100May require validation
Tomato (Solanum lycopersicum)Very Low1:25-1:50Not recommended
Wheat (Triticum aestivum)MinimalNot recommendedUse species-specific antibodies

The antibody targets a region in AUG8 that shows higher sequence divergence in monocots compared to dicots. When working with non-Arabidopsis species, researchers should:

  • Perform western blots to confirm specific binding at the expected molecular weight

  • Include peptide competition assays

  • Consider using alternative antibodies raised against conserved epitopes for cross-species studies

  • Validate with recombinant proteins from the species of interest

What approaches should researchers take to minimize cross-reactivity with other augmin complex proteins?

To minimize cross-reactivity with other augmin complex proteins:

  • Epitope selection strategy: The CSB-PA154725XA01DOA antibody targets unique regions of AUG8 that have minimal sequence homology with other augmin subunits (AUG1-7). Focus on the C-terminal region of AUG8 which shows the highest divergence.

  • Pre-absorption protocol: Incubate the antibody with recombinant AUG6 and AUG7 proteins (the most structurally similar augmin subunits) at a 10:1 (protein:antibody) ratio for 2 hours at room temperature before use.

  • Differentiating signal confirmation: Use dual-labeling with antibodies against other augmin subunits to distinguish between specific and non-specific signals.

  • Validation in genetic backgrounds: Compare antibody recognition patterns in wild-type plants versus aug8 knockouts and plants overexpressing specific augmin subunits.

  • Sequential immunoprecipitation: For interaction studies, perform sequential IPs to remove potential cross-reactive complexes before the main experimental IP.

Researchers should always include negative controls using pre-immune serum and perform western blots to confirm antibody specificity by molecular weight .

What methods can researchers use to identify potential off-target binding of AUG8 antibody in complex plant extracts?

To identify potential off-target binding of AUG8 antibody in complex plant extracts:

  • Immunoprecipitation followed by mass spectrometry:

    • Perform standard immunoprecipitation with AUG8 antibody

    • Analyze precipitated proteins by LC-MS/MS

    • Compare results from wild-type and aug8 mutant samples

    • Proteins present in both samples may represent off-targets

  • Two-dimensional western blotting:

    • Separate proteins by both isoelectric point and molecular weight

    • Perform western blotting with AUG8 antibody

    • Compare with theoretical position of AUG8

    • Additional spots indicate potential cross-reactivity

  • Protein array screening:

    • Use recombinant protein arrays containing Arabidopsis proteins

    • Probe with AUG8 antibody to identify all potential binding partners

    • Validate findings with reciprocal co-IP experiments

  • Competitive binding assays:

    • Pre-incubate antibody with increasing concentrations of purified AUG8 protein

    • Apply to western blots or immunostaining

    • Signals that remain despite competition represent non-specific binding

For greater confidence, combine multiple approaches and validate findings across different experimental conditions .

How can AUG8 antibody be utilized in studying plant responses to abiotic stress conditions?

For studying AUG8's role in abiotic stress responses:

  • Differential localization analysis:

    • Subject plants to various stresses (drought, cold, salt, heat)

    • Compare AUG8 localization patterns before and after stress

    • Quantify changes in nuclear vs. cytoplasmic distribution

    • Co-label with stress-responsive proteins to identify potential interactions

  • Phosphorylation-specific detection:

    • Generate phospho-specific AUG8 antibodies targeting key residues

    • Monitor phosphorylation status changes under stress conditions

    • Combine with phosphatase inhibitor treatments to preserve modifications

  • Microtubule array reorganization:

    • Use dual immunostaining with AUG8 and tubulin antibodies

    • Analyze colocalization coefficients during stress responses

    • Quantify microtubule density, orientation, and stability in relation to AUG8 localization

  • Chromatin association studies:

    • Perform ChIP-seq to identify stress-responsive genes associated with AUG8

    • Compare binding profiles under normal and stress conditions

    • Validate with reporter gene assays

The optimal protocol includes time-course experiments capturing early (0-30 minutes), intermediate (1-6 hours), and late (12-48 hours) responses to identify dynamic changes in AUG8 function during stress adaptation .

What are the methodological considerations when using AUG8 antibody in co-immunoprecipitation studies with potential interacting proteins?

For successful co-immunoprecipitation studies with AUG8 antibody:

  • Buffer optimization matrix:

Buffer ComponentRecommended RangeStringent ConditionsMild Conditions
Salt (NaCl)100-300mM300mM100mM
Detergent0.1-1% NP-40 or Triton X-1001%0.1%
pH7.0-8.07.07.5-8.0
Divalent cations1-5mM MgCl₂None2-5mM
Reducing agents0.5-5mM DTT0.5mM5mM
  • Antibody immobilization approaches:

    • Direct coupling to activated beads (high efficiency but may affect epitope)

    • Protein A/G-mediated binding (versatile but less stable)

    • Biotinylated antibody with streptavidin beads (strongest interaction)

  • Pre-clearing strategy:

    • Pre-clear lysates with isotype-matched control antibody

    • Include 1-2 hour incubation with beads alone before antibody addition

    • Add 1% BSA to reduce non-specific binding

  • Elution methods comparison:

    • Peptide competition elution (gentlest, preserves interactions)

    • pH gradient elution (intermediate stringency)

    • SDS elution (strongest, disrupts all interactions)

  • Controls framework:

    • Input lysate (5-10%)

    • IgG-matched negative control

    • Reverse co-IP with antibodies against interacting partners

    • aug8 knockout negative control

For studying transient or weak interactions, consider crosslinking with DSP (dithiobis(succinimidyl propionate)) before cell lysis .

How can researchers effectively integrate AUG8 antibody-based data with transcriptomics and proteomics data in systems biology approaches?

For integrating AUG8 antibody data with -omics approaches:

  • Multi-modal data integration workflow:

    • Generate AUG8 ChIP-seq, RNA-seq, and proteomics data from identical experimental conditions

    • Normalize datasets using appropriate batch correction methods

    • Apply time-series analysis for dynamic studies

  • Network construction methodology:

    • Use AUG8 ChIP-seq peaks to identify direct target genes

    • Correlate with RNA-seq expression changes in aug8 mutants

    • Integrate protein interaction data from co-IP/MS experiments

    • Apply Bayesian network algorithms to infer causal relationships

  • Validation strategy:

    • Select key nodes from network analysis for functional validation

    • Generate reporter constructs for AUG8-bound promoters

    • Perform directed protein-protein interaction studies

    • Use CRISPR/Cas9 to mutate specific binding sites

  • Visualization and analysis platforms:

    • Cytoscape with EnrichmentMap for network visualization

    • Gene Ontology enrichment analysis for functional clustering

    • GSEA for pathway analysis of AUG8-associated genes

    • STRING database integration for protein interaction networks

  • Statistical approaches:

    • Apply false discovery rate correction across all -omics datasets

    • Use ANOVA models to identify significant condition-dependent changes

    • Implement machine learning algorithms to classify AUG8-dependent responses

This integrative approach should include at least three biological replicates per condition and appropriate controls for each experimental method .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.